Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
G1 Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
GTHX
Nasdaq
8731
https://www.g1therapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for G1 Therapeutics Inc
G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
- May 3rd, 2024 10:46 am
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
- May 2nd, 2024 2:43 pm
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
- May 2nd, 2024 7:09 am
Q1 2024 G1 Therapeutics Inc Earnings Call
- May 2nd, 2024 3:04 am
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- May 1st, 2024 9:50 pm
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
- May 1st, 2024 11:54 am
G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
- May 1st, 2024 11:40 am
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
- May 1st, 2024 10:30 am
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
- May 1st, 2024 10:25 am
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit
- Apr 19th, 2024 2:49 pm
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
- Apr 17th, 2024 1:00 pm
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Apr 4th, 2024 2:30 pm
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:21 pm
Q4 2023 G1 Therapeutics Inc Earnings Call
- Feb 29th, 2024 4:09 am
G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
- Feb 28th, 2024 12:40 pm
G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023
- Feb 28th, 2024 11:51 am
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
- Feb 28th, 2024 11:30 am
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
- Feb 27th, 2024 1:30 pm
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions
- Feb 17th, 2024 1:47 pm
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
- Feb 15th, 2024 1:30 pm
Scroll